AIThe SaaS Newsabout 1 hour ago
Isomorphic Labs Raises $2.1B Series B
2 min read
Isomorphic Labs raised $2.1 billion in Series B funding led by Thrive Capital. Investors include Alphabet, GV, MGX, Temasek, CapitalG, and the UK Sovereign AI Fund. The London-based AI drug design company will scale its IsoDDE engine and expand its therapeutic pipeline globally.
Level
Hype check
Tap to vote and see what everyone thinks.
